(Total Views: 413)
Posted On: 06/09/2021 10:26:46 AM
Post# of 145871
it really is incredible how range-bound it's been at $2 - just bizarre.
given the incredibly low volume, the simplest answer is that no one is that motivated to buy - everyone is in "wait and see" mode. i think the shorts figure they've taken all of the blood out of the turnip (or whatever the saying is) at this point - and even they realize it's a dangerous game to short here.
so i guess we just float around here until the Brazil trial data comes out and maybe we see an approval. I really don't think long-haulers gets us much, given that it won't lead to approval. and the announcements of new trials, HIV prep, etc. that are "way out there somewhere" won't get us traction either - even though i love seeing that stuff.
the real irony is that stocks like AMC and GameStop attract all of this retail money and are up 15-30X this year. How can some of those people not be buying this stock right now? The potential is so much greater over the next couple years. oh well....
given the incredibly low volume, the simplest answer is that no one is that motivated to buy - everyone is in "wait and see" mode. i think the shorts figure they've taken all of the blood out of the turnip (or whatever the saying is) at this point - and even they realize it's a dangerous game to short here.
so i guess we just float around here until the Brazil trial data comes out and maybe we see an approval. I really don't think long-haulers gets us much, given that it won't lead to approval. and the announcements of new trials, HIV prep, etc. that are "way out there somewhere" won't get us traction either - even though i love seeing that stuff.
the real irony is that stocks like AMC and GameStop attract all of this retail money and are up 15-30X this year. How can some of those people not be buying this stock right now? The potential is so much greater over the next couple years. oh well....
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)